Skip to main content
. 2020 Apr;145(4):1157–1164.e6. doi: 10.1016/j.jaci.2019.12.010

Table E2.

Change in symptom control ≥minimum important difference for study population, and by severity definition

Population n Improved No change Worse McNemar
P value
Complete cohort
All ages 319 77 (24) 148 (46) 94 (29) .14
 2-4 y 60 19 (32) 17 (28) 24 (40) .54
 5+ y 259 58 (22) 131 (51) 70 (27) .18
 5-11 y 157 40 (25) 76 (48) 41 (26) .71
 12+ y 102 18 (18) 55 (54) 29 (28) .08
“Persistent poor control”
All ages 147 42 (29) 54 (37) 51 (35) .46
 2-4 y 45 17 (38) 10 (22) 18 (40) .95
 5+ y 102 25 (25) 44 (43) 33 (32) .32
 5-11 y 56 15 (27) 25 (45) 16 (29) .83
 12+ y 46 10 (22) 19 (41) 17 (37) .24
High-dose ICS
All ages 127 35 (28) 50 (39) 42 (33) .46
 2-4 y 33 13 (39) 7 (21) 13 (39) .84
 5+ y 94 22 (23) 43 (46) 29 (31) .26
 5-11 y 40 12 (30) 19 (48) 9 (22) .63
 12+ y 54 10 (19) 24 (44) 20 (37) .07
“Difficult asthma”
All ages 90 34 (38) 31 (34) 25 (28) .30
 2-4 y 37 15 (41) 9 (24) 13 (35) .58
 5+ y 53 19 (36) 22 (42) 12 (23) .23
 5-11 y 24 10 (42) 9 (38) 5 (21) .21
 12+ y 29 9 (31) 13 (45) 7 (24) .62

Values are n (%).

This severity definition is partially dependent on the (c)ACT score, so this P value may be influenced by regression to the mean.